Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of ≥300/mm3: CPCRA 059

Donald I. Abrams, Judith D. Bebchuk, Eileen T. Denning, Richard T. Davey, Lawrence Fox, H. Clifford Lane, James Sampson, Rita Verheggen, Douglas Zeh, Norman P. Markowitz

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of ≥300/mm3: CPCRA 059'. Together they form a unique fingerprint.

Medicine & Life Sciences